Aptus Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.8M Buy
79,754
+55,172
+224% +$4.92M 0.06% 286
2025
Q4
$1.94M Sell
24,582
-2,099
-8% -$165K 0.02% 450
2025
Q3
$2.13M Buy
26,681
+429
+2% +$36.6K 0.02% 424
2025
Q2
$2.39M Buy
26,252
+4,266
+19% +$389K 0.02% 390
2025
Q1
$2.06M Buy
21,986
+4,296
+24% +$385K 0.02% 390
2024
Q4
$1.61M Buy
17,690
+9,411
+114% +$898K 0.02% 433
2024
Q3
$859K Buy
8,279
+73
+0.9% +$7.44K 0.01% 439
2024
Q2
$796K Buy
8,206
+1,522
+23% +$140K 0.02% 423
2024
Q1
$602K Buy
6,684
+2,424
+57% +$205K 0.01% 472
2023
Q4
$340K Buy
4,260
+371
+10% +$27.9K 0.01% 446
2023
Q3
$277K Buy
+3,889
New +$291K 0.01% 491
2023
Q1
Sell
-4,499
Closed -$354K 808
2022
Q4
$354K Sell
4,499
-2
-0% -$150 0.01% 387
2022
Q3
$316K Buy
+4,501
New +$353K 0.01% 377
2022
Q2
Sell
-3,333
Closed -$253K 669
2022
Q1
$253K Buy
+3,333
New +$264K 0.01% 382

Other funds holding CL